The Supreme Court will review the ability of American women to easily access a commonly used abortion pill, the court announced Wednesday. Mifepristone has become central to the response by health care professionals and reproductive rights advocates to last year’s Supreme Court decision overturning Roe v. Wade. The pill can be transported across state and…  read on >  read on >

A healthy plant-based diet can reduce a person’s risk of type 2 diabetes by 24%, a new study has found. Eating plenty of fresh fruits, vegetables and whole grains has this protective effect even in people with a genetic predisposition for diabetes or risk factors like obesity, advanced age or lack of physical activity, researchers…  read on >  read on >

Doctor’s brains are great decision-makers, but even the smartest physicians might be well-served with a little diagnostic help from ChatGPT, a new study suggests. The main benefit comes from a thinking process known as “probabilistic reasoning” — knowing the odds that something will (or won’t) happen. “Humans struggle with probabilistic reasoning, the practice of making…  read on >  read on >

Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quit them within a year. The main factor: Gastrointestinal issues like nausea, vomiting…  read on >  read on >

The diabetes and weight-loss drug Ozempic does not appear to harm a developing fetus when taken by pregnant women, a new study reports. Researchers found no elevated risk of birth defects among newborns of women who took medications to control their type 2 diabetes, compared with those who took insulin. During the decade-long study, researchers…  read on >  read on >